243 related articles for article (PubMed ID: 26218149)
1. HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications.
Karabekian Z; Ding H; Stybayeva G; Ivanova I; Muselimyan N; Haque A; Toma I; Posnack NG; Revzin A; Leitenberg D; Laflamme MA; Sarvazyan N
Tissue Eng Part A; 2015 Oct; 21(19-20):2559-71. PubMed ID: 26218149
[TBL] [Abstract][Full Text] [Related]
2. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
3. Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives.
Zhao L; Teklemariam T; Hantash BM
Stem Cell Res; 2014 Sep; 13(2):342-54. PubMed ID: 25218797
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of beta-microglobulin to diminish T-lymphocyte lysis of non-syngeneic cell sources of engineered heart tissue constructs.
Karabekian Z; Idrees S; Ding H; Jamshidi A; Posnack NG; Sarvazyan N
Biomed Mater; 2015 Mar; 10(3):034101. PubMed ID: 25775354
[TBL] [Abstract][Full Text] [Related]
5. B-cell receptor-associated protein 31 regulates human embryonic stem cell adhesion, stemness, and survival via control of epithelial cell adhesion molecule.
Kim WT; Seo Choi H; Min Lee H; Jang YJ; Ryu CJ
Stem Cells; 2014 Oct; 32(10):2626-41. PubMed ID: 24898727
[TBL] [Abstract][Full Text] [Related]
6. Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin.
Lu P; Chen J; He L; Ren J; Chen H; Rao L; Zhuang Q; Li H; Li L; Bao L; He J; Zhang W; Zhu F; Cui C; Xiao L
Stem Cell Rev Rep; 2013 Dec; 9(6):806-13. PubMed ID: 23934228
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic properties and external factors determine the differentiation bias of human embryonic stem cell lines.
Mehta A; Mathew S; Viswanathan C; Sen Majumdar A
Cell Biol Int; 2010 Oct; 34(10):1021-31. PubMed ID: 20586725
[TBL] [Abstract][Full Text] [Related]
8. Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications.
de Peppo GM; Svensson S; Lennerås M; Synnergren J; Stenberg J; Strehl R; Hyllner J; Thomsen P; Karlsson C
Tissue Eng Part A; 2010 Jul; 16(7):2161-82. PubMed ID: 20136402
[TBL] [Abstract][Full Text] [Related]
9. In vitro neural differentiation of human embryonic stem cells using a low-density mouse embryonic fibroblast feeder protocol.
Ozolek JA; Jane EP; Esplen JE; Petrosko P; Wehn AK; Erb TM; Mucko SE; Cote LC; Sammak PJ
Methods Mol Biol; 2010; 584():71-95. PubMed ID: 19907972
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of adenovirus early region 1B-associated protein 5 as a surface marker on undifferentiated human embryonic stem cells.
Choi HS; Kim WT; Kim H; Kim JJ; Ko JY; Lee SW; Jang YJ; Kim SJ; Lee MJ; Jung HS; Kzhyshkowska J; Um SJ; Lee MY; Lee SH; Kim CH; Ryu CJ
Stem Cells Dev; 2011 Apr; 20(4):609-20. PubMed ID: 21083500
[TBL] [Abstract][Full Text] [Related]
11. HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.
Säljö K; Barone A; Mölne J; Rydberg L; Teneberg S; Breimer ME
Sci Rep; 2017 Oct; 7(1):13072. PubMed ID: 29026098
[TBL] [Abstract][Full Text] [Related]
12. Development of a decoy immunization strategy to identify cell-surface molecules expressed on undifferentiated human embryonic stem cells.
Choi HS; Kim H; Won A; Kim JJ; Son CY; Kim KS; Ko JH; Lee MY; Kim CH; Ryu CJ
Cell Tissue Res; 2008 Aug; 333(2):197-206. PubMed ID: 18560898
[TBL] [Abstract][Full Text] [Related]
13. Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity.
Chen Y; Zhou Y; Zhou Z; Fang Y; Ma L; Zhang X; Xiong J; Liu L
Stem Cell Res Ther; 2023 Jan; 14(1):11. PubMed ID: 36691086
[TBL] [Abstract][Full Text] [Related]
14. Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1 alpha promoter system.
Chan KK; Wu SM; Nissom PM; Oh SK; Choo AB
Stem Cells Dev; 2008 Aug; 17(4):825-36. PubMed ID: 18788934
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the self-renewal and pluripotency of human embryonic stem cells via the control of the G1/S transition.
Choi HS; Lee HM; Jang YJ; Kim CH; Ryu CJ
Stem Cells; 2013 Dec; 31(12):2647-58. PubMed ID: 23495120
[TBL] [Abstract][Full Text] [Related]
16. HLA engineering of human pluripotent stem cells.
Riolobos L; Hirata RK; Turtle CJ; Wang PR; Gornalusse GG; Zavajlevski M; Riddell SR; Russell DW
Mol Ther; 2013 Jun; 21(6):1232-41. PubMed ID: 23629003
[TBL] [Abstract][Full Text] [Related]
17. An efficient, economical slow-freezing method for large-scale human embryonic stem cell banking.
T'Joen V; De Grande L; Declercq H; Cornelissen M
Stem Cells Dev; 2012 Mar; 21(5):721-8. PubMed ID: 21635216
[TBL] [Abstract][Full Text] [Related]
18. Enrichment and purging of human embryonic stem cells by detection of cell surface antigens using the monoclonal antibodies TG30 and GCTM-2.
Polanco JC; Wang B; Zhou Q; Chy H; O'Brien C; Laslett AL
J Vis Exp; 2013 Dec; (82):50856. PubMed ID: 24335647
[TBL] [Abstract][Full Text] [Related]
19. Propensity of human embryonic stem cell lines during early stage of lineage specification controls their terminal differentiation into mature cell types.
Pal R; Totey S; Mamidi MK; Bhat VS; Totey S
Exp Biol Med (Maywood); 2009 Oct; 234(10):1230-43. PubMed ID: 19546356
[TBL] [Abstract][Full Text] [Related]
20. Primitive cardiac cells from human embryonic stem cells.
Hudson J; Titmarsh D; Hidalgo A; Wolvetang E; Cooper-White J
Stem Cells Dev; 2012 Jun; 21(9):1513-23. PubMed ID: 21933026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
